1Michel ML, Deng Q, Mancini-Bourgine M. Therapeutic vaccines and immune-based therapies for the treatment chronic hepatitis B: perspectives and challenges. Hepatol, 2011, 54(6): 1286-1296.
2Schmidt-Wolf IG, Negrin RS, Kiem HP, et al. Use of a SCID mouse/ human lymphoma model to evaluate cytokine--induced killer cells with potent antitumor cell activity. Exp Med, 1991, 174(1):139-149.
3Kim HM, Lira J, Park SK, et al. Antitumor activity of cytokine induced killer ceils against human lung cancer. Int Immunopharmacol, 2007, 7(13):1802.
